[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CTNM":3,"homepage-market-summary":31,"stock-news-CTNM":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CTNM","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Contineum Therapeutics, Inc. Class A Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.","51","San Diego, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},13.12,13.15,13.24,12.585,12.99,0.13,1,794232.860757,10026,13.031,17.785,8.6,318488.710909564,49.2,626,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":154},"success",[34,42,48,55,62,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":22,"is_up":40,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":40,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":40,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":40,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},13,[175,181,187,193,199,205,211,217,223,228,233,237,242],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"A 4,170-share sale is proposed by Contineum Therapeutics (CTNM) officer Daniel Lorrain. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxQUkZFaXJSNWRoNHhlNGh4MVlwanp2ZUduc0JwZ2xrNm9jZ0dZLU1KVXl4Nm5ZTkxTeDFIS1h4eHA0M3NralpLMUNiUWdCLUdyX094bWJiR1VKdzBCUXQwelFhU2xfTWVyUnJTazFQVUlwc2htTzNSTXRubjhEVUp6X0pSLVVhdmFDTmdyZkN6ejJDaVYwUjdGeHNyektkWFhJQkNBMW9n?oc=5","Thu, 01 Oct 2026 20:21:26 GMT","A 4,170-share sale is proposed by Contineum Therapeutics (CTNM) officer Daniel Lorrain. Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Market Movers | Winners: PACB, MNKD, CTNM | Losers: LQDA, GLAS, QNC - Trefis","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQXzB2ZEd2eTNXUFQ0WXJhcUtqTG1FX1ExUmNZMzlnblcxcDNRVFFEdTcxaFNtT0xVaDdCU1JPdENxU1ZoTU9rTnJjT3BRVDR0RGRkR1pUazVDNFV4cTREc2hyZlJuUG9jSnhmU0FPeTZjTDVCcXEtaUNmWi00ZVJtSVNTbl9RbDVBcFJZcUpZd2NaUHNUTTl4UlUxaGJHbkNLZk5Jam0yUS1TM19kY1UyMXJIcFlsVEZF?oc=5","Thu, 01 Oct 2026 08:52:58 GMT","Market Movers | Winners: PACB, MNKD, CTNM | Losers: LQDA, GLAS, QNC Trefis","Trefis",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"RBC Cuts Price Target on Contineum Therapeutics to $21 From $23, Keeps Outperform, Speculative Risk - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxPMGt6VC1xeXJIVl9xa242Yl9SZkJTZFdZVjgtcnZaWk9WV1c3eTN4WVR4cEttTEVjM0lTTHFTZ19Wbm5YYTM3ay1WaGx4amZkLXdpOU9EWUxzdjE0WmR2Q0F2QV9uQ2U5dEw3RnN0ZXVkVmI5Z2FMRUxSODdPWjdkUTFWWTBSamM1SWRmVjROU1BQbHZ5cHhmVGU5c24?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","RBC Cuts Price Target on Contineum Therapeutics to $21 From $23, Keeps Outperform, Speculative Risk Yahoo Finance","Yahoo Finance",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"(CTNM) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxPQkNSOC0wLVR1Nm1telB1c1NiSHZEaGNVZXp2bC10cEsxTnNaTkx2MUwtTmI2NzVYeS15QWg5TlFkUjN1Y1FtM0NJQ2ZBakxfWTBEZG5ESE5obnVTdGFnaXRSSm1Ja0ExdktsNjRzQVJ5c1BPYjN3aWVRX1dsdmhESWJ0cnJjbW5KSDBFOUhpbURLU0ZXXzI3TlQ2QnNNRTJHQnNmQTVCTl9FU1VqOTN6dkZnWFlMT1JPQ0JhY2hjLWg5NkdFbVFrM1JvUQ?oc=5","Sun, 27 Sep 2026 06:18:02 GMT","(CTNM) Price Dynamics and Execution-Aware Positioning Stock Traders Daily","Stock Traders Daily",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Stifel reiterates Contineum Therapeutics stock rating at buy - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNeEZlcjd5TGh2a1ZmZWExWFRoUm1qemROVUFIM1ZVUXRjTGl2Y1VrdU05aFpUYk55VXhkRDdjQ2o3RFEzd2dPN1BKY1p0NjVucVVPXzNyRHgwVFNKNkJfSzg5U215RHJqNEFfT1Rnd3M5T1E1LXdGcVg0QWhmQmUweXpjZHI4bTB4U29DdU50YWFjeEZWN1RCeVJ6bjhRZ3RXNEw2eGFzZ0NCcTdqRktEOGZjeWFkUWw1bEtESQ?oc=5","Wed, 30 Sep 2026 14:51:43 GMT","Stifel reiterates Contineum Therapeutics stock rating at buy Investing.com","Investing.com",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Contineum Therapeutics, Inc. Class A (CTNM) Receives a Buy from JonesTrading - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7gFBVV95cUxQeFYwdEl6eGZCOXo3aGdNWnp4TXFndUF5eEFTRG1wQ2xKTjJkU2JTd2ZjQW5FTFZZcURVMVVtVE1DeUgyVnBjZmcxRkcwM25jQmlxaFpWckhtc2VLdzE0ZnRoVGhKOTVWc1dRWWZyclNlaWpHMlV4UzI0M2JXeXJJQjNTc1hKajkxYlBUc1JJZWctZVBMRDViaUYyY2lFeF9iZklDOXYtMDZaMTFhcTkzdUV0dWpJcmpDSTJnbXhPeldPUE44RkJKMHFRUEl2QVV5VFhIZlR3ZUZIenRKMVJnQkIyQnA0YWZDSi1QUGtR?oc=5","Mon, 28 Sep 2026 22:00:00 GMT","Contineum Therapeutics, Inc. Class A (CTNM) Receives a Buy from JonesTrading The Globe and Mail","The Globe and Mail",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Stifel Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Maintains Target Price $28 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOYkVCRlBXZFlMUWczWFVCQ1pucHNBUGtxVXJUUFFkYU1yeVk5ZGZKMFk0OExpMFpUR2xYVFZ0ZVJnOUNaQmJJbXVJZkhXN1cwSlpVcE1DNS1GSERUSTN1b3EyTGVLQloxSzAzWXBod0VMaWVvUHhjY0xWdllCZXIyUXRGQm84ZjFKNnAyQ0d5eGszZ09uRzNsQXM2bV9OZ1c3czYyNXJMS1pjSS1ITEIxYjlPNmdBYjA4QUxBcGt5N00?oc=5","Wed, 30 Sep 2026 17:47:43 GMT","Stifel Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Maintains Target Price $28 Moomoo","Moomoo",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"RBC Cuts Price Target on Contineum Therapeutics to $21 From $23, Keeps Outperform, Speculative Risk - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxPMHloTFZYeHJieUR3WEcza3U4TjYzVDJqbFhFRGRPb0VoRUVHSWVzMkhRLUlEVWJTbmJWSGdybGxxdG5YbnFmaXExdDRfRU1fVHpaZkg0Q1J3NUdZaFJMSFFpRmUyVlpXYmhUcTRLNUlUUXVRVVRXaDJyTFUzNkxuNXBaNFBIS3hsczNpRXBrbW16TVJsdWJmYkJjdzg3SWhUbC1iZTUtN01BWnZjM3YwbDBRNm9yb0ZxcXBnQ2RvajFiMmNyV19rYTRfUGREcEJqY1dBcjktM3BpWHI2YU1TVVdR?oc=5","Mon, 21 Sep 2026 10:34:49 GMT","RBC Cuts Price Target on Contineum Therapeutics to $21 From $23, Keeps Outperform, Speculative Risk marketscreener.com","marketscreener.com",{"title":224,"link":225,"pubDate":226,"description":227,"source":210},"Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from JonesTrading - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6AFBVV95cUxPbjNWZnpsaWNGc0VRQzdIeXg1d1dFMFFPd2hZbTQ5UXZ1bWpaWUNhcTN0aVF1OC02bHpQLWdZcTBOUUloSDJIanZVc2hzRUk0S0xCc09WbDN1eFhzYk5xMEc1R2pPMTd3QmZKZVgzUzJ3V3lHX0M1WTViRjBnaWtaOWU5RlVUa3ZscEtqXzVZVkg0R19yVjBoNlFDaG5Td3QwS2VYQTBieXZRNXRiZF9oaXhPZS1vTzE4Z3JCRU54cmZQVXpyTGZ6Mk9xNzd6ME83Z3NqQk5SYUxrSGF1cGZCT3ZVM1d1cmll?oc=5","Thu, 01 Oct 2026 14:16:00 GMT","Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from JonesTrading The Globe and Mail",{"title":229,"link":230,"pubDate":231,"description":232,"source":204},"Goldman Sachs initiates coverage on Contineum Therapeutics stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxNNV9WczViclpzd3FhcEZXSFVvTEVQYmNjX3NZX0hwcTM3RHd4Mk01dTVEcHpnMWJjQWFEa2xaZTdRa0Z4a2p4UmV4QU1YTGJES1lTUEg1TzZ4TGcxQm9zdUV1RjEtVWlfSkRvNV8zT3RGMjFmWkNTa0JmNjQ1c0JkcElRaW1aVVZTem1wRVpidTRFSy1obUxOZnFOenA0Qjk1ZF8ySTQxRTF4WVl6Wl9RUWZRYUNJekVITU96UlJqY1BNQQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Goldman Sachs initiates coverage on Contineum Therapeutics stock Investing.com",{"title":234,"link":235,"pubDate":226,"description":236,"source":210},"Stifel Nicolaus Keeps Their Buy Rating on Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi_AFBVV95cUxPZUxhRUJhZmRrYXhvd01BellQT2IwOVA3MFoweERxYVJGdDEwRVY4Q0FwWjJwYWpkbFdlSFkwU1N0SmVzWVhFMXlMS1BsZklacnc0WUVxcy1Pd0hiOUt6NXhiZjNyZEM1Q2pxdzZTUlp3Wm9yZklHdHJHR2NvV09faERCWlo4X2dURGVJUnNnX2Y5Sk85eXpUUS1rOExTcldZRlRHYXhfUk01TU92X0ZmeGVGaEc1WnhNd1M2Y3JOUlU1LTRwNTN3c0hlTm5ZVmNXaGNCcG5mckdKWnFKR0dTVEdFYldfNHBwb1NLZ2M4NDdZMlBJLU4yNDc1YTk?oc=5","Stifel Nicolaus Keeps Their Buy Rating on Contineum Therapeutics, Inc. Class A (CTNM) The Globe and Mail",{"title":238,"link":239,"pubDate":240,"description":241,"source":210},"RBC Capital Sticks to Their Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-wFBVV95cUxQV3VzV3J3VFV0NmQ2c1haNVlMRHFKZTNkb2tNbnBhdEhBdlg4ME1hRHF3MGpHa1VMaTFYQWR4ZDM3dk9Dd2lFNDYtdHoxakpESFBsYTctT3BxS09rZEdYSmpJWHZ6cVVyd3JRNEsydFpiLTFVZVZYUzhVOHBuRkZ4T1hoVnA2TktLV1pkOUpaLUtRZGcxVUNIQTZyUkYxWXB4MDFGTTU4dnV1enVSY24zb3A5a3dsVDNBM0pwVGpFRS1VZ0dVVnU0Z29WU2wzME9YUVZkU0hnOTJsb3h1WGNXT3J5TENiaTNWbzg0M1JUR2cySW5jemt2aTRHMA?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","RBC Capital Sticks to Their Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM) The Globe and Mail",{"title":243,"link":244,"pubDate":245,"description":246,"source":210},"Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxNZ2xmUk5uR3VyYlBPSDJ5NUE2NzB2SXFFVUMwdXZjQ2Z6RFBvV3BNakhEMHlmWkFvemVRSGc4MHY0RGlIaTd2WFMzd3BiRFVSeEgwY2QyV1ZyZENNSS1IZmZ6QXV3VnFjTGlEYUVDa1pwNzdpTWVhbjZXanpHb0RrT3NLWDlIbkQyalN6S3dnQ2xEVWJBaTI0cThZbFRMeWZPQUhDXzVBek5kZTcxUUVMcTZNV3NxelpVaUFFTHhFZU9HNmdSUVFwT0xSRFNQclRPN05XNjhDdjQ?oc=5","Thu, 01 Oct 2026 12:24:00 GMT","Wall Street Analysts Are Bullish on Top Healthcare Picks The Globe and Mail"]